4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
NeuroOne Medical Technologies Corporation (NMTC) operates in the Medical Devices industry and is headquartered in Eden Prairie, United States with about 18 employees. Its market capitalization is roughly $24 million. In the fiscal year ended 2025-09-30, NMTC reported $9M in revenue and ($4M) in net income.
NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States.
Interactive charts & full statements → Open the NMTC valuation workbench →
| Income statement | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|---|
| Total Revenue | $9M | $4M | $2M | $0M | — |
| Gross Profit | $5M | $1M | $0M | ($0M) | — |
| Operating Income (EBIT) | ($4M) | ($12M) | ($12M) | ($10M) | — |
| Net Income | ($4M) | ($12M) | ($12M) | ($10M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $2M | $3M | $3M | $2M | $1M | — |
| Gross Profit | $1M | $2M | $2M | $1M | $1M | — |
| Operating Income (EBIT) | ($2M) | ($2M) | ($1M) | ($2M) | ($3M) | — |
| Net Income | ($2M) | ($1M) | ($2M) | ($2M) | ($2M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|---|
| Total Assets | $11M | $5M | $8M | $13M | — |
| Total Liabilities | $4M | $4M | $2M | $3M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive NMTC viewer.
About TickerBase · Data methodology & sources